TRIM24 has been shown to be oncogenic, and its expression is positively associated with the poor survival of patients with various cancers, such as bladder cancer,5 gastric cancer,6 human HCC,7 nonsmall cell lung cancer,8 breast cancer,9 head and neck cancer.10 Here, TRIM24 is linked to breast carcinoma.